• Jobs
  • Startups
  • Hire
LoginSign up

Autobahn Therapeutics

Autobahn Therapeutics has 2 open roles. Funding stage: Series C. Last round: Jul 24, 2024.

Open roles

  • Autobahn Therapeutics logo
    Vice President, Medical Affairs and Professional Relations

    Autobahn Therapeutics

    • San Diego, CA
    • On-site · Director / Executive
    autobahntx.com
  • Autobahn Therapeutics logo
    Associate Director/ Director, Clinical Scientist

    Autobahn Therapeutics

    • San Diego, CA
    • On-site · Director / Executive
    autobahntx.com

About

Autobahn Therapeutics logo

Autobahn Therapeutics

Autobahn Therapeutics is a biotechnology company developing a portfolio of neuropsychiatric and neuroimmunologic clinical candidates leveraging its brain-targeting chemistry platform. Autobahn aims to unlock new therapeutic opportunities through precision tuning of CNS exposure, pursuing validated clinical and biologic targets, and guiding development with biomarkers. The company’s pipeline is led by ABX-002, a thyroid hormone receptor beta agonist being developed as a potential adjunctive treatment for people with major depressive disorder and bipolar disorder depression. Autobahn Therapeutics is based in San Diego.

Series C
Founded2017
HQSan Diego, United States
Size11–50 employees
Unlock human wisdom
ThesisTermsPrivacy
Industry
Biotechnology Research
Funding
  • Series C · Jul 24, 2024

Claim autobahntx.com

Work at autobahntx.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.